Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 171 for Prostate cancer

Edit search filters
  1. A Study Of Androgen Annihilation In High-Risk Biochemically Relapsed Prostate Cancer

    Scottsdale/Phoenix, AZ

  2. A Study To Evaluate The Feasibility Of Daily, Long-Term, Intermittent Fasting For Men On PSA Surveillance Following Radical Prostatectomy

    Rochester, MN

  3. Rapid-Plan Knowledge-Based Planning Vs. Human-Driven Planning For Prostate Cancer Radiotherapy

    Scottsdale/Phoenix, AZ

  4. A Study To Assess Multiparametric MRI In Evaluating Cancer Stage And Helping Treatment Planning In Patients With Prostate Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Study To Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT In Men With Hormone Sensitive Prostate Cancer And Raise Of Prostate Specific Antigen (PSA) Levels After Local Therapies (ARASTEP)

    Scottsdale/Phoenix, AZ

  6. Focal Laser Ablation Of Prostate Cancer Tumors

    Rochester, MN

  7. A Study Of Standard Systemic Therapy With Or Without Definitive Treatment In Treating Participants With Metastatic Prostate Cancer

    Scottsdale/Phoenix, AZ, La Crosse, WI, Rochester, MN

  8. Study Of Pembrolizumab (MK-3475) Combination Therapies In Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. S1216, Phase III ADT+TAK-700 Vs. ADT+Bicalutamide For Metastatic Prostate Cancer

    Rochester, MN

  10. A Study to Compare Docetaxel/Prednisone to Docetaxel/Prednisone Combined with OGX-011 in Men with Prostate Cancer

    Rochester, MN

.

Mayo Clinic Footer